1
|
Tuchynskaya K, Volok V, Illarionova V, Okhezin E, Polienko A, Belova O, Rogova A, Chernokhaeva L, Karganova G. Experimental Assessment of Possible Factors Associated with Tick-Borne Encephalitis Vaccine Failure. Microorganisms 2021; 9:1172. [PMID: 34072340 PMCID: PMC8229799 DOI: 10.3390/microorganisms9061172] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2021] [Revised: 05/26/2021] [Accepted: 05/27/2021] [Indexed: 12/30/2022] Open
Abstract
Currently the only effective measure against tick-borne encephalitis (TBE) is vaccination. Despite the high efficacy of approved vaccines against TBE, rare cases of vaccine failures are well documented. Both host- and virus-related factors can account for such failures. In this work, we studied the influence of mouse strain and sex and the effects of cyclophosphamide-induced immunosuppression on the efficacy of an inactivated TBE vaccine. We also investigated how an increased proportion of non-infectious particles in the challenge TBE virus would affect the protectivity of the vaccine. The vaccine efficacy was assessed by mortality, morbidity, levels of viral RNA in the brain of surviving mice, and neutralizing antibody (NAb) titers against the vaccine strain and the challenge virus. Two-dose vaccination protected most animals against TBE symptoms and death, and protectivity depended on strain and sex of mice. Immunosuppression decreased the vaccine efficacy in a dose-dependent manner and changed the vaccine-induced NAb spectrum. The vaccination protected mice against TBE virus neuroinvasion and persistence. However, viral RNA was detected in the brain of some asymptomatic animals at 21 and 42 dpi. Challenge with TBE virus enriched with non-infectious particles led to lower NAb titers in vaccinated mice after the challenge but did not affect the protective efficacy.
Collapse
Affiliation(s)
- Ksenia Tuchynskaya
- FSBSI “Chumakov FSC R&D IBP RAS”, 108819 Moscow, Russia; (K.T.); (V.V.); (V.I.); (E.O.); (A.P.); (O.B.); (A.R.); (L.C.)
| | - Viktor Volok
- FSBSI “Chumakov FSC R&D IBP RAS”, 108819 Moscow, Russia; (K.T.); (V.V.); (V.I.); (E.O.); (A.P.); (O.B.); (A.R.); (L.C.)
- Department of Biology, Lomonosov Moscow State University, 119991 Moscow, Russia
| | - Victoria Illarionova
- FSBSI “Chumakov FSC R&D IBP RAS”, 108819 Moscow, Russia; (K.T.); (V.V.); (V.I.); (E.O.); (A.P.); (O.B.); (A.R.); (L.C.)
- Department of Biology, Lomonosov Moscow State University, 119991 Moscow, Russia
| | - Egor Okhezin
- FSBSI “Chumakov FSC R&D IBP RAS”, 108819 Moscow, Russia; (K.T.); (V.V.); (V.I.); (E.O.); (A.P.); (O.B.); (A.R.); (L.C.)
- Department of Biology, Lomonosov Moscow State University, 119991 Moscow, Russia
| | - Alexandra Polienko
- FSBSI “Chumakov FSC R&D IBP RAS”, 108819 Moscow, Russia; (K.T.); (V.V.); (V.I.); (E.O.); (A.P.); (O.B.); (A.R.); (L.C.)
| | - Oxana Belova
- FSBSI “Chumakov FSC R&D IBP RAS”, 108819 Moscow, Russia; (K.T.); (V.V.); (V.I.); (E.O.); (A.P.); (O.B.); (A.R.); (L.C.)
| | - Anastasia Rogova
- FSBSI “Chumakov FSC R&D IBP RAS”, 108819 Moscow, Russia; (K.T.); (V.V.); (V.I.); (E.O.); (A.P.); (O.B.); (A.R.); (L.C.)
| | - Liubov Chernokhaeva
- FSBSI “Chumakov FSC R&D IBP RAS”, 108819 Moscow, Russia; (K.T.); (V.V.); (V.I.); (E.O.); (A.P.); (O.B.); (A.R.); (L.C.)
| | - Galina Karganova
- FSBSI “Chumakov FSC R&D IBP RAS”, 108819 Moscow, Russia; (K.T.); (V.V.); (V.I.); (E.O.); (A.P.); (O.B.); (A.R.); (L.C.)
- Department of Biology, Lomonosov Moscow State University, 119991 Moscow, Russia
- Institute of Translational Medicine and Biotechnology, Sechenov First Moscow State Medical University, 119991 Moscow, Russia
| |
Collapse
|
2
|
Kholodilov I, Belova O, Burenkova L, Korotkov Y, Romanova L, Morozova L, Kudriavtsev V, Gmyl L, Belyaletdinova I, Chumakov A, Chumakova N, Dargyn O, Galatsevich N, Gmyl A, Mikhailov M, Oorzhak N, Polienko A, Saryglar A, Volok V, Yakovlev A, Karganova G. Ixodid ticks and tick-borne encephalitis virus prevalence in the South Asian part of Russia (Republic of Tuva). Ticks Tick Borne Dis 2019; 10:959-969. [PMID: 31103456 DOI: 10.1016/j.ttbdis.2019.04.019] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2018] [Revised: 04/03/2019] [Accepted: 04/25/2019] [Indexed: 12/15/2022]
Abstract
The most significant processes of arbovirus evolution can be expected to occur in the territories where ticks of different species cohabitate and at the boundaries of virus occurrence, where the probability of the appearance of new virus variants is high due to the possible shift in the main vectors and/or vertebrate hosts. One of the most interesting regions in this regard is the Republic of Tuva. Since most of its territory is covered by mountain ranges and intermountain basins, we were able to study the distribution of vectors and viruses in geographically isolated areas at different altitudes and in various landscapes. From 2008 to 2017, we conducted six expeditions to Tuva and collected 3,077 adult ticks and 24 nymphs. The distribution of tick species was confined to specific landscapes, as follows: Dermacentor nuttalli occurred in steppes, D. silvarum inhabited forest-steppe areas, and Ixodes persulcatus inhabited mixed forests. All three species of ticks were collected on plains and mountain slopes. The range of D. silvarum was shown to be lower than 1300 m above sea level (a.s.l.). Only D. nuttalli and I. persulcatus were collected at higher altitudes. According to our observations, single nymphs of D. nuttalli appear on animals one month before larvae appear. This finding confirms the hypothesis that the immature forms of D. nuttalli are able to overwinter under favourable conditions. We isolated 9 strains and 3 isolates of tick-borne encephalitis virus (TBEV) from I. persulcatus, one strain from D. nuttalli and one strain from D. silvarum. The TBEV strain from D. nuttalli was isolated from the territory inhabited only by Dermacentor ticks. All isolated strains belong to the Siberian subtype of TBEV. TBEV was detected in ticks from all the investigated altitudes. There were no statistically significant differences in the virus prevalence between the Dermacentor and Ixodes ticks. The results of our work provide additional support for the hypothesis of the existence of TBEV foci in areas with an absolute dominance of D. nuttalli.
Collapse
Affiliation(s)
- Ivan Kholodilov
- Chumakov Institute of Poliomyelitis and Viral Encephalitides (FSBSI "Chumakov FSC R&D IBP RAS), prem. 8, k.17, pos. Institut Poliomyelita, poselenie Moskovskiy, Moscow 108819, Russia.
| | - Oxana Belova
- Chumakov Institute of Poliomyelitis and Viral Encephalitides (FSBSI "Chumakov FSC R&D IBP RAS), prem. 8, k.17, pos. Institut Poliomyelita, poselenie Moskovskiy, Moscow 108819, Russia; Martsinovsky Institute of Medical Parasitology, Tropical and Vector Borne Diseases, Sechenov University, Malaya Pirogovskaya st., 20-1, Moscow 119435, Russia.
| | - Ludmila Burenkova
- Chumakov Institute of Poliomyelitis and Viral Encephalitides (FSBSI "Chumakov FSC R&D IBP RAS), prem. 8, k.17, pos. Institut Poliomyelita, poselenie Moskovskiy, Moscow 108819, Russia.
| | - Yuri Korotkov
- Chumakov Institute of Poliomyelitis and Viral Encephalitides (FSBSI "Chumakov FSC R&D IBP RAS), prem. 8, k.17, pos. Institut Poliomyelita, poselenie Moskovskiy, Moscow 108819, Russia.
| | - Lidiya Romanova
- Chumakov Institute of Poliomyelitis and Viral Encephalitides (FSBSI "Chumakov FSC R&D IBP RAS), prem. 8, k.17, pos. Institut Poliomyelita, poselenie Moskovskiy, Moscow 108819, Russia; I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Trubetskaya st., 8-2, Moscow 119991, Russia.
| | - Lola Morozova
- Department of Tropical Medicine and Parasitic Diseases, Sechenov University, Trubetskaya st., 8-2, Moscow 119991, Russia.
| | - Vitalii Kudriavtsev
- Chumakov Institute of Poliomyelitis and Viral Encephalitides (FSBSI "Chumakov FSC R&D IBP RAS), prem. 8, k.17, pos. Institut Poliomyelita, poselenie Moskovskiy, Moscow 108819, Russia.
| | - Larissa Gmyl
- Chumakov Institute of Poliomyelitis and Viral Encephalitides (FSBSI "Chumakov FSC R&D IBP RAS), prem. 8, k.17, pos. Institut Poliomyelita, poselenie Moskovskiy, Moscow 108819, Russia.
| | - Ilmira Belyaletdinova
- Chumakov Institute of Poliomyelitis and Viral Encephalitides (FSBSI "Chumakov FSC R&D IBP RAS), prem. 8, k.17, pos. Institut Poliomyelita, poselenie Moskovskiy, Moscow 108819, Russia.
| | - Alexander Chumakov
- Tuvinian Antiplague Station of Rospotrebnadzor, Moskovskaya st., 13, Kyzyl 667010, Russia.
| | - Natalia Chumakova
- Tuvinian Antiplague Station of Rospotrebnadzor, Moskovskaya st., 13, Kyzyl 667010, Russia.
| | - Oyumaa Dargyn
- Tuva Republican Center for Disease Prevention and Control of AIDS and Infectious disease, Oyuna Kursedi st., 159A, Kyzyl 667003, Russia.
| | - Nina Galatsevich
- Tuvinian Antiplague Station of Rospotrebnadzor, Moskovskaya st., 13, Kyzyl 667010, Russia.
| | - Anatoly Gmyl
- Chumakov Institute of Poliomyelitis and Viral Encephalitides (FSBSI "Chumakov FSC R&D IBP RAS), prem. 8, k.17, pos. Institut Poliomyelita, poselenie Moskovskiy, Moscow 108819, Russia.
| | - Mikhail Mikhailov
- I. Mechnikov Research Institute of Vaccines and Sera of the Russian Academy of Medical Sciences, Malyy Kazennyy pereulok, 5a, Moscow 105064, Russia.
| | - Natalia Oorzhak
- Infectious disease hospital, Chekhova st., 65, Kyzyl 667003, Russia.
| | - Alexandra Polienko
- Chumakov Institute of Poliomyelitis and Viral Encephalitides (FSBSI "Chumakov FSC R&D IBP RAS), prem. 8, k.17, pos. Institut Poliomyelita, poselenie Moskovskiy, Moscow 108819, Russia.
| | - Anna Saryglar
- Infectious disease hospital, Chekhova st., 65, Kyzyl 667003, Russia.
| | - Viktor Volok
- Chumakov Institute of Poliomyelitis and Viral Encephalitides (FSBSI "Chumakov FSC R&D IBP RAS), prem. 8, k.17, pos. Institut Poliomyelita, poselenie Moskovskiy, Moscow 108819, Russia; Peoples' Friendship University of Russia (RUDN University), Miklukho-Maklaya st., 6, Moscow 105064, Russia.
| | - Alexander Yakovlev
- Chumakov Institute of Poliomyelitis and Viral Encephalitides (FSBSI "Chumakov FSC R&D IBP RAS), prem. 8, k.17, pos. Institut Poliomyelita, poselenie Moskovskiy, Moscow 108819, Russia.
| | - Galina Karganova
- Chumakov Institute of Poliomyelitis and Viral Encephalitides (FSBSI "Chumakov FSC R&D IBP RAS), prem. 8, k.17, pos. Institut Poliomyelita, poselenie Moskovskiy, Moscow 108819, Russia; I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Trubetskaya st., 8-2, Moscow 119991, Russia.
| |
Collapse
|